The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats
Abstract
Heart failure is known to be a complication of insulin-dependent (IDDM) and noninsulin-dependent diabetes mellitus (NIDDM) even in the absence of coronary heart disease or hypertension. The mechanisms leading to diabetic cardiomyopathy are unknown. The aim of the study was to characterize structural and functional alterations in hyperinsulinemic Zucker diabetic fatty (ZDF) rats treated with or without insulin. Diabetic animals showed a twofold increase in cardiomyocyte volume with increased left ventricular ANP but not BNP mRNA levels in spite of a reduced plasma renin activity (PRA) 2 months after onset of diabetes compared to nondiabetic littermates. These changes were associated with an increase in left ventricular performance as assessed by echocardiography. Insulin treatment led to a significant increase in body weight (BW), total heart weight, myocardial protein content, and left ventricular mass (LVM). Perivascular fibrosis and laminin thickness were significantly augmented in diabetic rat myocardium irrespective of insulin treatment, whereas interstitial collagen I and fibronectin were similarly found in diabetic and control myocardium. Initial stages of diabetic cardiomyopathy in hyperinsulinemic rats are characterized by cardiomyocyte hypertrophy and enhanced cardiac contractility. It is suggested that hyperinsulinemia may be involved in cardiac hypertrophy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In genetically obese Zucker fatty rats, LVH is present in young animals shortly after the development of diabetes. This is associated with increased LV function by echocardiography (104); however, they eventually develop significant LV dysfunction in vivo as evidenced by decreased fractional shortening. This can be reversed with TZD treatment (394).”
From Cardiac remodeling in obesity (2008) · cites this paper as [104]
Citations
Cites
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4
Katz, E. B., Stenbit, A. E., Hatton, K. S., DePinho, R. A., & Charron, M. J. (1995) · Nature · doi:10.1038/377151a0 · Cited by 467
Litwin, S. E., Katz, S. E., Morgan, J. P., & Douglas, P. S. (1994) · Circulation · doi:10.1161/01.cir.89.1.345 · Cited by 420
Sympathetic and Cardiorenal Actions of Leptin
Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., & Mark, A. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.619 · Cited by 351
Zucker Diabetic Fatty Rat as a Model for Non-insulin-dependent Diabetes Mellitus
Peterson, R., Shaw, W., Neel, M., Little, L., & Eichberg, J. (1990) · ILAR Journal · doi:10.1093/ilar.32.3.16 · Cited by 339
Myocyte Death in Streptozotocin-Induced Diabetes in Rats Is Angiotensin II- Dependent
Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E. H., Anversa, P., Leri, A., & Kajstura, J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780057 · Cited by 289
Cited by
Sorted by citations
Items 101–115 of 115
The impact of the extracellular matrix and type 1 diabetes on cardiac fibroblast activation
Shamhart, P. E. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Cardiac remodelling in hypertrophic cardiomyopathy and diabesity
Lim, W. (2017) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.4225/55/58b65fe5db46e
Mátyás, C., Sayour, A. A., Korkmaz‐Icöz, S., Oláh, A., Németh, B. T., Páli, S., Hirschberg, K., Zubarevich, A., Gwanmesia, P., Li, S., et al. (2017) · Cardiologia Hungarica · doi:10.26430/chungarica.2017.47.2.102
“Korábbi kutatási eredményekkel összhangban jelen vizsgálatunkban is igazoltuk, hogy a diabéteszhez társuló szívizom-hipertrófi a mindkét DM esetén kialakul (9, 24, 25).”
Mineralocorticoid Receptor and Leptin: A Dangerous Liaison in the Obese Heart
Marín‐Royo, G., Luaces, M., Cachofeiro, V., & Martínez‐Martínez, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87236
D’Souza, A. (2011) · CLOK (University of Central Lancashire)
Federico, M. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/115958
Biomarkers of Myocardial Fibrosis in Diabetes, Echocardiography, and Magnetic Resonance Imaging
Madsen, P. L. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_45
Wu, X. Y., Trzeciakowski, J. P., Meininger, G. A., & Muthuchamy, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.15.516690
“During progress of diabetes, there is an increase in expression and deposition of fibronectin (FN) and collagen (CN) in non-CVM compartments (4, 27, 28, 47, 49, 60, 67).”
BackgroundShmygol, A., Bru‐Mercier, G., Sultan, A. S., & Howarth, F. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.03.610949
Obesity-Associated Cardiac Fibrosis: Mechanisms and Emerging Therapeutic Targets
Zhou, D., Tan, Y., Zhao, J., Wang, S., Wang, Z., Bai, M., Niu, X., & Zhang, Z. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s567568
“237”
New biomarkers and therapeutic targets in left ventricular hypertrophy
Evaristi, M. F. (2017) · theses.fr (ABES) · doi:10.70675/0d048706z75d9z4ea2za46fz8f14c110ade5
Novak, A., Baglaeva, I., Bervanlou, R. N., Iaparov, B. I., Zahradnı́ková, A., Cagalinec, M., Novotová, M., & Zahradníková, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.18.732821
Nowaczyk, R., Kuropka, P., Szumny, A. J., Pachura, N., Zwyrzykowska-Wodzińska, A., Pogoda-Sewerniak, K., & Kupczyński, R. (2026) · Molecules · doi:10.3390/molecules31142487
“Histologically, animals in the CTRL group exhibited the following characteristic features of DCM: structural remodeling; minor and moderate interstitial and perivascular fibrosis; cardiomyocyte hypertrophy; and increased myocardial cell death [61].”
Novak, A., Baglaeva, I., Bervanlou, R. N., Iaparov, B. I., Zahradníková, A., Cagalinec, M., Novotová, M., & Zahradníková, A. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2026
Metadata
- Authors
- Fredersdorf, S., Thumann, C., Ulucan, C., Griese, D. P., Luchner, A., Riegger, G. A. J., Kromer, E. P., & Weil, J.
- Affiliations
- University Hospital Regensburg (DE)
- Corresponding author
- Weil, Joachim
- Venue
- Cardiovascular Pathology
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 13
- Issue
- 1
- Pages
- 11-19
- ISSN
- 1054-8807 (ISSN-L)
- OpenAlex
- W2165355897
- Cited by
- 115
- References
- 46
- Citations by year
- 2026: 5 · 2024: 2 · 2022: 9 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 8 · 2016: 2 · 2015: 8 · 2014: 5 · 2013: 5 · 2012: 7
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Pathology (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- Funders
- Universität Regensburg
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- diabetic cardiomyopathy, cardiac hypertrophy, left ventricular contractility, hyperinsulinemia, insulin therapy, Zucker diabetic fatty rats, heart failure, atrial natriuretic peptide, brain natriuretic peptide, plasma renin activity, myocardial fibrosis, laminin, type I collagen, fibronectin, left ventricular mass, cardiomyocyte volume
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Echocardiography, Fibronectins, Fibrosis, Cardiomegaly, Heart Ventricles, Hyperinsulinism, Image Processing, Computer-Assisted, Immunohistochemistry, Insulin, Laminin, Male, Myocardial Contraction, Myocardium, Atrial Natriuretic Factor, Rats, Zucker, RNA, Messenger, Blotting, Northern, Ventricular Function, Collagen Type I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
